PharmaCorp Rx Inc. (TSXV:PCRX)
Canada · Delayed Price · Currency is CAD 0.4800
-0.0100 (-2.04%)
At close: May 12, 2026
PharmaCorp Rx Revenue
In the year 2025, PharmaCorp Rx had annual revenue of 20.89M CAD with 260.57% growth. PharmaCorp Rx had revenue of 7.69M in the quarter ending December 31, 2025, with 74.80% growth.
Revenue
20.89M
Revenue Growth
+260.57%
P/S Ratio
4.08
Revenue / Employee
n/a
Employees
n/a
Market Cap
85.30M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 20.89M | 15.10M | 260.57% |
| Dec 31, 2024 | 5.79M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curaleaf Holdings | 1.79B |
| Extendicare | 1.75B |
| Green Thumb Industries | 1.67B |
| Sienna Senior Living | 1.05B |
| Decibel Cannabis Company | 112.72M |
| Vext Science | 70.43M |
| Charlotte's Web Holdings | 68.41M |
| Theralase Technologies | 816.47K |
PharmaCorp Rx News
- 21 days ago - PharmaCorp Rx Transcript: 2026 Bloom Burton & Co. Healthcare Investor Conference - Transcripts